	Roles of macrophages in tumor immunotherapy: metabolism, immune checkpoints, and combination strategies. J Zhejiang Univ Sci B Wang S, Fu Y, Huang Y. PMID: 42928018 [PubMed - indexed for MEDLINE]
	Diagnosed Dental Diseases, Tooth Loss and the Risk of Primary Liver Cancer in a Nationwide Swedish Cohort. J Clin Periodontol Zhong Q, Ruan Z, Yin L, Adami HO, Ye W. PMID: 42927980 [PubMed - as supplied by publisher]
	Systematic Review and Meta-Analysis of Patients with Esophageal Cancer and Intramural Metastasis. Ann Thorac Cardiovasc Surg Sato S, Shimada H, Takeda Y, Endo I, Yoshikawa T. PMID: 42927908 [PubMed - indexed for MEDLINE]
	Alcohol Non-Abstinence and Hypertension as Independent Risk Factors for Esophageal Cancer Recurrence After Endoscopic Submucosal Dissection: A Multicenter Cohort Study. Kurume Med J Emori K, Fukunaga S, Mukasa M, Nakane T, Cho T, Minami S, Tanaka H, Ohzono D, Yoshio T, Watanabe Y, Nakano D, Tsutsumi T, Araki T, Morita T, Torimura T, Nouno R, Takedatsu H, Kawaguchi T. PMID: 42927902 [PubMed - as supplied by publisher]
	ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2. Nature McGrath L, Kar G, Bonanno L, Guisier F, Insa A, Liberman M, Bylicki O, Livi L, Egenod T, Corre R, Kim DW, Garcia Campelo MR, Provencio Pulla M, Shim BY, Metro G, Bennouna J, Bielska AA, Yohannes AR, Shaju J, He Y, Dowson A, Grenga I, Spicer J, Forde PM, Cascone T. PMID: 42927884 [PubMed - as supplied by publisher]
	Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer: First Results from the Global AZUR-1 Trial. Ann Oncol Cercek A, Bachet JB, Folprecht G, Bando H, Seligmann J, Starling N, Riesco-Martinez MC, Alfonso PG, Smith D, Salvatore L, Flores EG, Mitry E, Chen E, Castillon JC, Morano F, Keränen SR, Aubin F, López CL, Lonardi S, Buchschacher G Jr, Roderburg C, Gerlinger M, Modest D, Heinemann V, Goetze TO, Kato T, Park YS, Perkins G, Lemay F, Vickers M, Szijgyarto Z, Stjepanovic N, Haftchenary S, Diaz LA Jnr, Roodhart JML. PMID: 42927858 [PubMed - as supplied by publisher]
	Pembrolizumab plus lenvatinib with belzutifan or quavonlimab as first-line therapy for advanced renal-cell carcinoma: randomized open-label phase 3 LITESPARK-012 study. Ann Oncol Rini BI, Choueiri TK, Voss MH, Burotto M, Oldenburg J, Gurney HP, Ferguson TR, Hammers H, Albiges L, Ürün Y, Romero Diaz RI, Özgüro, Weber PY, Verzoni E, Porta C, Drakaki A, Guo J, Matsubara N, Chen A, Burgents JE, Rodriguez-Lopez KG, Powles TB. PMID: 42927856 [PubMed - as supplied by publisher]
	Final prespecified analysis of the phase 3 LITESPARK-011 study: belzutifan plus lenvatinib versus cabozantinib for advanced renal cell carcinoma after anti-PD-(L)1 therapy. Ann Oncol Heng DYC, Schmidinger M, McDermott R, Park SH, Burotto M, Ciccarese C, Verzoni E, Suárez C, Eto M, Cutuli HJ, Porta C, Kopp RM, Rottey S, de Velasco G, Valderrama BP, Azad AA, De Giorgi U, Pavic M, Tomczak P, Figlin R, Westgeest HM, Guida A, Necchi A, Schutz FA, Suelmann BBM, Haanen JB, Lin J, Perini RF, Vickery D, Motzer RJ, LITESPARK-011 Investigators. PMID: 42927855 [PubMed - as supplied by publisher]
	A randomised phase III trial of adjuvant treatment intensification with mFOLFIRINOX versus mFOLFOX6 in high-risk stage III colon cancer: Results of the international IROCAS study. Ann Oncol Bennouna J, André T, Martin E, Cremolini C, Gill S, Asmis T, Kavan P, Mitry E, Hiret S, Mineur L, Artru P, Perret C, Bouché O, Touchefeu Y, Goldenberg B, Dupuis O, Lonardi S, Chibaudel B, Castanié H, Coutzac C, Bauguion L, Guardiola E, Benmaziane A, Barrière J, Chen E, Simmet V, Allegrini G, Marmorino F, Pezzella V, Monard L, Campion L, O'Callaghan C, Taieb J. PMID: 42927853 [PubMed - as supplied by publisher]
	Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol Tao K, Lin Z, Zhang P, Chi P, Xiao Y, Hou Z, Xu X, Zhang A, Qiu X, Wu J, Yuan Y, Wang Z, Qu X, Li X, Nie X, Yang M, Cai K, Wang Z, Zhang W, Huang Y, Sun Z, Zheng R, Zhao F, Han C, Zhang T. PMID: 42927765 [PubMed - as supplied by publisher]
	Acridone Acetic Acid (CMA) Activates STING Signaling in Human Myeloid Leukemia Cells and Sensitizes Them to Venetoclax. Biochemistry (Mosc) Nevzorov IA, Korableva P, Shuvalov O, Parfenyev S, Daks A. PMID: 42927750 [PubMed - indexed for MEDLINE]
	The Dual Role of Cell Death in Cancer Pathogenesis and Antitumor Therapy: From Linear Models to Integrative Representations. Biochemistry (Mosc) Kuligina ES, Yanus GA, Imyanitov EN. PMID: 42927740 [PubMed - indexed for MEDLINE]
	Postoperative radiotherapy for early oral squamous cell carcinoma with a single ipsilateral lymph node metastasis - a retrospective cohort study. J Craniomaxillofac Surg Alkhateeb A, Hawas B, Brinks R, Hassfeld S, Alsharif U. PMID: 42927708 [PubMed - as supplied by publisher]
	Appetite loss in patients with cancer: A cross-sectional study of contextual influences and patient-reported self-management strategies. Eur J Oncol Nurs Tobberup R, Christensen ME, Lang NR, Schnieber A, Mehlsen MY. PMID: 42927679 [PubMed - as supplied by publisher]
	The Role of Self-Collection in Optimising Cervical Screening for People With Intellectual Disability: A Multi Perspective Qualitative Study. Health Expect Winkler L, Power R, Allison KR, Strnadová I, Carter A, Ussher J, Jolly H, Basckin C, Sweeney S, Loblinzk J, Bateson D. PMID: 42927653 [PubMed - indexed for MEDLINE]
	Molecular mechanisms and targeted therapeutic strategies of TIGAR in regulating energy metabolism to promote tumor proliferation in breast cancer. Breast Cancer Zhai M, Wang P, Ou Y. PMID: 42927599 [PubMed - as supplied by publisher]
	Peripheral immune tolerance as a driver of tumor immune escape and therapy resistance. Clin Transl Oncol Vaishnave S, Jayaraj A, Selvaraj J, Ramachandiran S, Natarajan M, Gunasekaran B, Lokaiah T. PMID: 42927598 [PubMed - as supplied by publisher]
	Prognostic associations between patient-reported outcomes and progression-free and overall survival in advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1 TAP scoreâ€‰â‰¥â€‰5%: results from the RATIONALE-305 trial. Qual Life Res Moehler M, Correa MC, Oh DY, Xu RH, Kato K, Barzi A, Barnes FB, Xu Y, Sheng T, Barnes G, Victor T. PMID: 42927580 [PubMed - indexed for MEDLINE]
	Androgen receptor signaling in hepatocellular carcinoma: mechanisms of male predominance and therapeutic opportunities. Mol Biol Rep Zhou Y, Qin Y. PMID: 42927579 [PubMed - indexed for MEDLINE]
	Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study. Mol Biol Rep Canchi Sistla H, Seshachalam A, Rathnam KK, Rajagopal T, Talluri S, Venkatabalasubramanian S, Dunna NR. PMID: 42927554 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 1983750

Page 1 of 99188



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy